Literature DB >> 27112096

Does treatment by a specialist physiotherapist change pain and function in young adults with symptoms from femoroacetabular impingement? A pilot project for a randomised controlled trial.

Alison Smeatham1, Roy Powell2, Sarah Moore3, Rohan Chauhan2, Matthew Wilson4.   

Abstract

AIM: Femoroacetabular impingement (FAI) is recognised as a source of hip pain but the effect of conservative treatment remains untested. This pilot study aimed to inform and evaluate the methods required to conduct a substantive trial comparing the effect of treatment by a physiotherapist versus routine care on the symptoms of FAI.
DESIGN: A parallel group, pilot randomised controlled trial (RCT).
SETTING: A single NHS acute hospital trust, Devon, England. PARTICIPANTS: 30 adults with symptomatic FAI were recruited. 23 (77%) completed the study.
INTERVENTIONS: Intervention was 3 months of treatment by a specialist physiotherapist. The control group received routine care. MAIN OUTCOMES: Change in pain and function was measured using a Visual Analogue Scale, Non Arthritic Hip Score (NAHS), Lower Extremity Functional Score (LEFS) and Hip Outcome Score.
RESULTS: Participants in the intervention arm undertook a personalised exercise programme to improve pelvic and femoral control plus advice on posture, activity pacing and pain relief. The mean change in NAHS for the intervention group was 12.7 (95% CI 4.7 to 20.7) and 1.8 (95% CI -5.3 to 9.0) in the control group; Median change in LEFS was 11.5 (95% CI 5.0 to 26.0) versus -1.0 (95% CI -7.0 to 4.0). This improvement in LEFS was beyond minimal clinically important difference in the intervention group. Pain scores improved marginally in both groups.
CONCLUSIONS: Methodological strengths and weaknesses were successfully identified for a substantive study. Further research is needed to evaluate the relative influence of structural and neuromuscular features on symptoms of FAI and the role of conservative treatment.
Copyright © 2016 Chartered Society of Physiotherapy. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Femoroacetabular impingement (FAI); Function; Pain; Physiotherapy; RCT

Mesh:

Year:  2016        PMID: 27112096     DOI: 10.1016/j.physio.2016.02.004

Source DB:  PubMed          Journal:  Physiotherapy        ISSN: 0031-9406            Impact factor:   3.358


  6 in total

1.  NON-OPERATIVE MANAGEMENT OF INDIVIDUALS WITH NON-ARTHRITIC HIP PAIN: A LITERATURE REVIEW.

Authors:  Ryan P McGovern; RobRoy L Martin; Benjamin R Kivlan; John J Christoforetti
Journal:  Int J Sports Phys Ther       Date:  2019-02

2.  SHORT-TERM OUTCOMES OF CONSERVATIVE TREATMENT FOR FEMOROACETABULAR IMPINGEMENT: A SYSTEMATIC REVIEW AND META-ANALYSIS.

Authors:  Emma Mallets; Ann Turner; Jeremy Durbin; Alexander Bader; Leigh Murray
Journal:  Int J Sports Phys Ther       Date:  2019-07

3.  A randomized controlled trial protocol for an interdisciplinary evaluation of non-arthritic hip disease.

Authors:  Lindsey Brown; Marcie Harris-Hayes; Randi Foraker; Kathryn Glaws; W Kelton Vasileff; Stephanie Di Stasi
Journal:  Eur J Pers Cent Healthc       Date:  2019

4.  Hip arthroscopy results in improved patient reported outcomes compared to non-operative management of waitlisted patients.

Authors:  Luke Spencer-Gardner; Ruch Dissanayake; Amir Kalanie; Parminder Singh; John O'Donnell
Journal:  J Hip Preserv Surg       Date:  2017-01-10

Review 5.  Conservative vs. Surgical Management for Femoro-Acetabular Impingement: A Systematic Review of Clinical Evidence.

Authors:  Giuseppe Anzillotti; Alberto Iacomella; Matteo Grancagnolo; Enrico Maria Bertolino; Maurilio Marcacci; Cristiano Sconza; Elizaveta Kon; Berardo Di Matteo
Journal:  J Clin Med       Date:  2022-10-02       Impact factor: 4.964

6.  Improving function in people with hip-related pain: a systematic review and meta-analysis of physiotherapist-led interventions for hip-related pain.

Authors:  Joanne L Kemp; Andrea B Mosler; Harvi Hart; Mario Bizzini; Steven Chang; Mark J Scholes; Adam I Semciw; Kay M Crossley
Journal:  Br J Sports Med       Date:  2020-05-06       Impact factor: 13.800

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.